Actively Recruiting

Age: 18Months +
All Genders
Healthy Volunteers
ID02461446

Natural History Study of Individuals With Autism and Germline Heterozygous PTEN Mutations

Led by Boston Children's Hospital · Updated on 2024-10-26

170

Participants Needed

5

Research Sites

52 weeks

Total Duration

On this page

Sponsors

B

Boston Children's Hospital

Lead Sponsor

N

National Institutes of Health (NIH)

Collaborating Sponsor

AI-Summary

What this Trial Is About

Researchers are studying individuals with autism spectrum disorders (ASD) who have germline heterozygous PTEN mutations, a genetic subgroup that may represent a significant portion of ASD cases. This study aims to compare medical, behavioral, and cognitive differences between PTEN ASD and other groups, and to identify specific cognitive, neural, and molecular biomarkers for PTEN ASD. The research will also create and maintain a biorepository and linked phenotypic database focused on this condition. Participants will include individuals with PTEN ASD, those with macrocephalic ASD without PTEN mutations (macro-ASD), healthy controls, and individuals with PTEN mutations but no ASD (PTEN no-ASD). The study involves three on-site visits over two years, each lasting about 4 to 6 hours. Visits include physical exams, medical history reviews, neuropsychological assessments, and blood draws for lab studies. Children aged 2 to 11 may also participate in an EEG portion. Participants with clinically indicated MRIs can optionally provide scans for analysis. During participation, individuals will undergo various assessments such as changes in verbal abilities, communication, visual perception, working memory, and processing speed at 12 and 24 months. The study also includes physical exams and collection of medical and behavioral data. Participants will be monitored over the two-year period with three visits to track longitudinal changes and biomarkers associated with PTEN ASD. The research is observational and includes healthy volunteers as well.

CONDITIONS

Brief Title

Natural History Study of Individuals With Autism and Germline Heterozygous PTEN Mutations

Who Can Participate

Age: 18Months +
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Individuals aged 18 months or older at the time of consent
  • Clinical diagnosis of autism spectrum disorder and/or verified PTEN mutation confirmed by a medical or mental health professional
  • Macrocephaly (head circumference at or above the 98th percentile) for the ASD macrocephaly group
  • Consent from parents or legal guardians for youths; self-consent or legal guardian consent for adults
  • Assent from youths who are able, according to IRB guidelines
  • Families with multiple eligible children may enroll each child separately
  • Primary communicative language must be English
Not Eligible

You will not qualify if you...

  • Unwilling or unable to comply with study procedures and assessments
  • Clinically significant medical conditions that prevent participation in study procedures
  • Contraindications to 3T MRI scanning for those eligible for imaging biomarker assessment, such as metal implants or incompatible medical devices
  • Contraindications to EEG/ERP assessments, including uncooperative or destructive behaviors preventing proper equipment use
  • Age under 2 years or over 11 years at enrollment for EEG/ERP biomarker assessment

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Monitoring

Duration - 2 years

Participants attend three on-site visits over two years involving physical exams, medical history questions, neuropsychological assessments, and blood draws. A subset aged 2 to 11 years may undergo EEG assessments, and participants with clinically indicated MRIs may provide routine clinical scans for analysis.

3 visits (in-person) over 2 years

Trial Site Locations

Total: 5 locations

1

University of California at Los Angeles

Los Angeles, California, United States, 90095

Actively Recruiting

2

Stanford University Medical Center

Stanford, California, United States, 94305

Actively Recruiting

3

Boston Children's Hospital

Boston, Massachusetts, United States, 02115

Actively Recruiting

4

Cincinnati Children's Hospital Medical Center

Cincinnati, Ohio, United States, 45229

Actively Recruiting

5

Cleveland Clinic

Cleveland, Ohio, United States, 44195

Actively Recruiting

Loading map...

Research Team

R

Rajna Filip-Dhima, MS

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

3

Similar Trials

An Open-label Study Evaluating DT402 in Adults With Autism S...

Autism Spectrum Disorder

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Published Research Related To This Trial

Cross-level analysis of molecular and neurobehavioral function in a prospective series of patients with germline heterozygous PTEN mutations with and without autism.

Thomas W Frazier, Ritika Jaini, Robyn M Busch...

https://pubmed.ncbi.nlm.nih.gov/33509259